HW211026

DRUG2 trials

Sponsors

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

Conditions

Actinic KeratosisActinic Keratosis (AK)

Phase 1

A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.

RecruitingNCT07318675

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.Actinic Keratosis (AK)

Start: 2025-12-25End: 2026-03-31Target: 40Updated: 2026-01-06

Phase 2

A Phase 2 Study of HW211026

Not yet recruitingNCT07513454

Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.Actinic Keratosis

Start: 2026-07-01End: 2027-12-01Target: 80Updated: 2026-07-09